Percutaneous Transesophageal Gastrostomy (PTEG): A Safe and Effective Technique for Gastrointestinal Decompression in Malignant Obstruction and Massive Ascites
Suthep Udomsawaengsup, MD; Jeffrey Landers, MD; Stacy Brethauer, MD; Tracy Pitt, DO; Silas Chikunguwoo, MD; Valentine Nfonsam, MD; Bipan Chand, MD
| Product Details | |
| Product ID: | ACS-2627 |
| Year Produced: | 2007 |
| Length: | 7 min. |
Percutaneous Transesophageal Gastrostomy (PTEG) was developed in 1998 as an alternative for patients with PEG contraindications. We chose PTEG for a patient with malignant obstruction.
The device was placed in the cervical esophagus. By placing a rupture free balloon in the cervical esophagus, the internal jugular vein and carotid artery were displaced laterally, the trachea and thyroid were displaced medially. With the use of transcutaneous ultrasonography and fluoroscopy, the guide wire was introduced into the esophagus, and a decompressing PTEG tube was safely placed from the left, cervical esophagus into the stomach.
The PTEG decompressed the stomach and allowed drainage.
Percutaneous Transesophageal Gastrotomy is a safe and an effective technique for gastrointestinal decompression in patients with malignant obstruction or massive ascites.
